Point72 (DIFC)’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Point72 (DIFC)'s DGX Position: Q3 2025 in Review
Point72 (DIFC) opened a new position in Quest Diagnostics (DGX) in Q3 2025: 35,400 shares worth $6.75M. The stake represents 0.44% of the portfolio and ranks #62 among its holdings. This is a return to the name: Point72 (DIFC) previously reported a position in DGX as recently as Q2 2024.
Point72 (DIFC) first reported a position in DGX in Q2 2024 and has held it in 2 quarters since. 1,005 funds tracked by Wall St. Rank hold DGX as of Q3 2025.
- Point72 (DIFC) held 35,400 shares of Quest Diagnostics worth $6.75M as of Q3 2025.
- Quest Diagnostics was a new Point72 (DIFC) position in Q3 2025.
- Quest Diagnostics made up 0.44% of Point72 (DIFC)'s portfolio in Q3 2025, its #62 holding.
- Point72 (DIFC) first reported a position in Quest Diagnostics in Q2 2024 and has held it in 2 quarters since.
- 1,005 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.
Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.